Effect of Blood Flow Restriction on Pain Perception, Grip Strength and Nerve Conductivity in CTS Patients.
Launched by CAIRO UNIVERSITY · Aug 26, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a technique called blood flow restriction (BFR) training can help people with carpal tunnel syndrome (CTS). The main goal is to see if BFR training can reduce pain, improve grip strength, and not change how well the nerves work in CTS patients. Participants will be divided into two groups: one group will receive standard physical therapy, while the other group will get both the standard therapy and the BFR training.
To join the study, participants need to be women aged 30 to 55 who have been diagnosed with carpal tunnel syndrome and have experienced symptoms like numbness or pain in their hands. Unfortunately, those who have had surgery for carpal tunnel or have certain other health conditions, such as diabetes or heart problems, cannot participate. If you join, you can expect to receive either the standard therapy or the combination of therapy and BFR training, and this could help improve your symptoms. The trial is currently recruiting participants, so it’s a great opportunity to contribute to research that might help others with similar issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. patients diagnosed by a physician according to the American Academy of Orthopedic Surgeon with carpal tunnel syndrome (CTS).
- • 2. age:30-55 years old.
- • 3. females.
- • 4. positive clinical provocative tests for CTS (Tinel test and Phalen test).
- • 5. subjects with a history of paresthesia, numbness, or pain in the median nerve distribution, night waking, and nocturnal pain.
- Exclusion Criteria:
- • 1. subjects who had carpal tunnel release surgery.
- • 2. subjects with cervical disc prolapse.
- • 3. subjects with cervical spondylosis.
- • 4. subjects with thoracic outlet syndrome (TOS).
- • 5. subjects with diabetes.
- • 6. subjects with gestational diabetes.
- • 7. subjects with cardiovascular disorders.
- • 8. subjects with hypertension.
- • 9. pregnant women.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed M El Melhat, Phd
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported